Skip to main content

Paired Ends: Tim Hague

Premium

Genomics data analysis developer Omixon said this week that it has named Tim Hague as CEO, taking over for Founder Attila Berces, who will continue to serve as chairman of the board of directors.

Hague has worked in software engineering and design at Lufthansa Systems and as a technical team leader at IBM.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.